| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |